인간성장호르몬 시장 : 세계 산업 분석, 규모, 점유율, 성장, 동향, 예측(2023-2031년)
Human Growth Hormone Market (Route of Administration: Intravenous, Subcutaneous, Intramuscular, and Oral) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2023-2031
상품코드:1420929
리서치사:Transparency Market Research
발행일:2023년 12월
페이지 정보:영문 170 Pages
라이선스 & 가격 (부가세 별도)
한글목차
인간성장호르몬 시장 - 보고서 범위
세계의 인간성장호르몬 시장에 관한 TMR의 보고서는 과거와 현재의 성장 동향 및 2023년부터 2031년까지의 예측기간 동안 시장 지표의 귀중한 인사이트를 얻을 수 있는 기회를 연구하고 있습니다. 2023년을 기준 연도, 2031년을 예측 연도로 삼아 2017년부터 2031년까지의 세계 시장 매출을 제공합니다. 또한 2023년부터 2031년까지 연평균 성장률(CAGR %)도 제공합니다.
이 보고서는 광범위한 조사를 통해 작성되었습니다. 1차 조사에서는 조사 활동의 대부분이 이루어지고, 애널리스트가 주요 오피니언 리더, 업계 리더, 오피니언 메이커와의 인터뷰를 실시했습니다. 2차 조사에는 인간성장호르몬 시장을 이해하기 위해 주요 기업의 제품 문헌, 연차 보고서, 프레스 릴리스 및 관련 문서에 대한 참조가 포함됩니다.
시장 현황
2023년 시장 가치
28억 달러
2031년 시장 가치
39억 달러
CAGR
3.7%
이 보고서는 세계의 인간성장호르몬 시장 경쟁 상황을 자세히 살펴봅니다. 세계의 인간성장호르몬 시장에서 활동하고 있는 주요 기업이 확인되었으며, 이들 각각이 다양한 속성의 관점에서 프로파일링됩니다. 기업 개요, 재무 상황, 최근의 동향, SWOT는 이 보고서에서 소개되고 있는 세계의 인간성장호르몬 시장 기업의 속성입니다.
목차
제1장 서문
제2장 가정과 조사 방법
제3장 주요 요약 : 세계 시장
제4장 시장 개요
서론
개요
시장 역학
세계 시장 분석과 예측, 2023-2031년
제5장 중요한 인사이트
파이프라인 분석
주요 인수합병
COVID-19 감염증 팬데믹이 업계에 미치는 영향
제6장 세계 시장 분석과 예측 : 투여 경로별
서론과 정의
주요 조사 결과/발전
시장 금액 예측 : 투여 경로별, 2023-2031
정맥내
피하
근육내
경구
시장 매력도 분석 : 투여 경로별
제7장 세계 시장 분석과 예측 : 유통 채널별
서론과 정의
주요 조사 결과/발전
시장 금액 예측 : 유통 채널별, 2023-2031
병원 약국
온라인 약국
소매 약국
클리닉
시장 매력도 분석 : 유통 채널별
제8장 세계 시장 분석과 예측 : 적응증별
서론과 정의
주요 조사 결과/발전
시장 금액 예측 : 적응증별, 2023-2031
성장호르몬결핍증
터너증후군
특발성 저신장
프라더 윌리 증후군
기타 적응증
시장 매력도 분석 : 적응증별
제9장 세계 시장 분석과 예측 : 지역별
주요 조사 결과
시장 금액 예측 : 지역별, 2023-2031
북미
유럽
아시아태평양
라틴아메리카
중동 및 아프리카
시장 매력도 분석 : 지역별
제10장 북미 시장 분석과 예측
제11장 유럽 시장 분석과 예측
제12장 아시아태평양 시장 분석과 예측
제13장 라틴아메리카 시장 분석과 예측
제14장 중동 및 아프리카 시장 분석과 예측
제15장 경쟁 상황
시장 기업 - 경쟁 매트릭스(기업 계층 및 규모별)
시장 점유율 분석 : 기업별(2022년)
기업 개요
Merck KGaA
Eli Lilly and Company
Pfizer Inc
Novo Nordisk A/S
Ipsen SA
Roche Holdings, Inc
Anhui Anke Biotechnology(Group) Co., Ltd.
Biopartners GmbH
GeneScience Pharmaceuticals Co., Ltd.
Novartis AG
KSM
영문 목차
영문목차
Human Growth Hormone Market - Scope of Report
TMR's report on the global human growth hormone market studies the past as well as the current growth trends and opportunities to gain valuable insights of the indicators of the market during the forecast period from 2023 to 2031. The report provides revenue of the global human growth hormone market for the period 2017-2031, considering 2023 as the base year and 2031 as the forecast year. The report also provides the compound annual growth rate (CAGR %) of the global human growth hormone market from 2023 to 2031.
The report has been prepared after an extensive research. Primary research involved bulk of the research efforts, wherein analysts carried out interviews with key opinion leaders, industry leaders, and opinion makers. Secondary research involved referring to key players' product literature, annual reports, press releases, and relevant documents to understand the human growth hormone market.
Market Snapshot
Market Value in 2023
US$ 2.8 Bn
Market Value in 2031
US$ 3.9 Bn
CAGR
3.7%
Secondary research also included Internet sources, statistical data from government agencies, websites, and trade associations. Analysts employed a combination of top-down and bottom-up approaches to study various attributes of the global human growth hormone market.
The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments included in the scope of the study. Moreover, the report throws light on the changing competitive dynamics in the global human growth hormone market. These serve as valuable tools for existing market players as well as for entities interested in participating in the global human growth hormone market.
The report delves into the competitive landscape of the global human growth hormone market. Key players operating in the global human growth hormone market have been identified and each one of these has been profiled in terms of various attributes. Company overview, financial standings, recent developments, and SWOT are the attributes of players in the global human growth hormone market profiled in this report.
Key Questions Answered in Global human growth hormone Market Report:
What is the sales/revenue generated by human growth hormone across all regions during the forecast period?
What are the opportunities in the global human growth hormone market?
What are the major drivers, restraints, opportunities, and threats in the market?
Which regional market is set to expand at the fastest CAGR during the forecast period?
Which segment is expected to generate the highest revenue globally in 2031?
Which segment is projected to expand at the highest CAGR during the forecast period?
What are the market positions of different companies operating in the global market?
Human Growth Hormone Market - Research Objectives and Research Approach
The comprehensive report on the global human growth hormone market begins with an overview, followed by the scope and objectives of the study. The report provides detailed explanation of the objectives behind this study and key vendors and distributors operating in the market and regulatory scenario for approval of products.
For reading comprehensibility, the report has been compiled in a chapter-wise layout, with each section divided into smaller ones. The report comprises an exhaustive collection of graphs and tables that are appropriately interspersed. Pictorial representation of actual and projected values of key segments is visually appealing to readers. This also allows comparison of the market shares of key segments in the past and at the end of the forecast period.
The report analyzes the global human growth hormone market in terms of product, end-user, and region. Key segments under each criterion have been studied at length, and the market share for each of these at the end of 2031 has been provided. Such valuable insights enable market stakeholders in making informed business decisions for investment in the global human growth hormone market.
Table of Contents
1. Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary: Global Human Growth Hormone Market
4. Market Overview
4.1. Introduction
4.1.1. Product Definition
4.1.2. Industry Evolution/Developments
4.2. Overview
4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunities
4.4. Global Human Growth Hormone Market Analysis and Forecast, 2023-2031
5. Key Insights
5.1. Pipeline Analysis
5.2. Key Mergers & Acquisitions
5.3. COVID-19 Pandemic Impact on Industry
6. Global Human Growth Hormone Market Analysis and Forecast, by Route of Administration
6.1. Introduction & Definition
6.2. Key Findings/Developments
6.3. Market Value Forecast, by Route of Administration, 2023-2031
6.3.1. Intravenous
6.3.2. Subcutaneous
6.3.3. Intramuscular
6.3.4. Oral
6.4. Market Attractiveness Analysis, by Route of Administration
7. Global Human Growth Hormone Market Analysis and Forecast, by Distribution Channel
7.1. Introduction & Definition
7.2. Key Findings/Developments
7.3. Market Value Forecast, by Distribution Channel, 2023-2031
7.3.1. Hospital Pharmacy
7.3.2. Online Pharmacy
7.3.3. Retail Pharmacy
7.3.4. Clinics
7.4. Market Attractiveness Analysis, by Distribution Channel
8. Global Human Growth Hormone Market Analysis and Forecast, by Indication
8.1. Introduction & Definition
8.2. Key Findings/Developments
8.3. Market Value Forecast, by Indication, 2023-2031
8.3.1. Growth Hormone Deficiency
8.3.2. Turner Syndrome
8.3.3. Idiopathic Short Stature
8.3.4. Prader-Willi Syndrome
8.3.5. Other Indications
8.4. Market Attractiveness Analysis, by Indication
9. Global Human Growth Hormone Market Analysis and Forecast, by Region
9.1. Key Findings
9.2. Market Value Forecast, by Region, 2023-2031
9.2.1. North America
9.2.2. Europe
9.2.3. Asia Pacific
9.2.4. Latin America
9.2.5. Middle East & Africa
9.3. Market Attractiveness Analysis, by Region
10. North America Human Growth Hormone Market Analysis and Forecast
10.1. Introduction
10.2. Key Findings
10.3. Market Value Forecast, by Route of Administration, 2023-2031
10.3.1. Intravenous
10.3.2. Subcutaneous
10.3.3. Intramuscular
10.3.4. Oral
10.4. Market Value Forecast, by Distribution Channel, 2023-2031
10.4.1. Hospital Pharmacy
10.4.2. Online Pharmacy
10.4.3. Retail Pharmacy
10.4.4. Clinics
10.5. Market Value Forecast, by Indication, 2023-2031
10.5.1. Growth Hormone Deficiency
10.5.2. Turner Syndrome
10.5.3. Idiopathic Short Stature
10.5.4. Prader-Willi Syndrome
10.5.5. Other Indications
10.6. Market Value Forecast, by Country, 2023-2031
10.6.1. U.S.
10.6.2. Canada
10.7. Market Attractiveness Analysis
10.7.1. By Route of Administration
10.7.2. By Distribution Channel
10.7.3. By Indication
10.7.4. By Country
11. Europe Human Growth Hormone Market Analysis and Forecast
11.1. Introduction
11.2. Key Findings
11.3. Market Value Forecast, by Route of Administration, 2023-2031
11.3.1. Intravenous
11.3.2. Subcutaneous
11.3.3. Intramuscular
11.3.4. Oral
11.4. Market Value Forecast, by Distribution Channel, 2023-2031
11.4.1. Hospital Pharmacy
11.4.2. Online Pharmacy
11.4.3. Retail Pharmacy
11.4.4. Clinics
11.5. Market Value Forecast, by Indication, 2023-2031
11.5.1. Growth Hormone Deficiency
11.5.2. Turner Syndrome
11.5.3. Idiopathic Short Stature
11.5.4. Prader-Willi Syndrome
11.5.5. Other Indications
11.6. Market Value Forecast, by Country/Sub-region, 2023-2031
11.6.1. Germany
11.6.2. U.K.
11.6.3. France
11.6.4. Italy
11.6.5. Spain
11.6.6. Rest of Europe
11.7. Market Attractiveness Analysis
11.7.1. By Route of Administration
11.7.2. By Distribution Channel
11.7.3. By Indication
11.7.4. By Country/Sub-region
12. Asia Pacific Human Growth Hormone Market Analysis and Forecast
12.1. Introduction
12.2. Key Findings
12.3. Market Value Forecast, by Route of Administration, 2023-2031
12.3.1. Intravenous
12.3.2. Subcutaneous
12.3.3. Intramuscular
12.3.4. Oral
12.4. Market Value Forecast, by Distribution Channel, 2023-2031
12.4.1. Hospital Pharmacy
12.4.2. Online Pharmacy
12.4.3. Retail Pharmacy
12.4.4. Clinics
12.5. Market Value Forecast, by Indication, 2023-2031
12.5.1. Growth Hormone Deficiency
12.5.2. Turner Syndrome
12.5.3. Idiopathic Short Stature
12.5.4. Prader-Willi Syndrome
12.5.5. Other Indications
12.6. Market Value Forecast, by Country/Sub-region, 2023-2031
12.6.1. China
12.6.2. Japan
12.6.3. India
12.6.4. Australia & New Zealand
12.6.5. Rest of Asia Pacific
12.7. Market Attractiveness Analysis
12.7.1. By Route of Administration
12.7.2. By Distribution Channel
12.7.3. By Indication
12.7.4. By Country/Sub-region
13. Latin America Human Growth Hormone Market Analysis and Forecast
13.1. Introduction
13.2. Key Findings
13.3. Market Value Forecast, by Route of Administration, 2023-2031
13.3.1. Intravenous
13.3.2. Subcutaneous
13.3.3. Intramuscular
13.3.4. Oral
13.4. Market Value Forecast, by Distribution Channel, 2023-2031
13.4.1. Hospital Pharmacy
13.4.2. Online Pharmacy
13.4.3. Retail Pharmacy
13.4.4. Clinics
13.5. Market Value Forecast, by Indication, 2023-2031
13.5.1. Growth Hormone Deficiency
13.5.2. Turner Syndrome
13.5.3. Idiopathic Short Stature
13.5.4. Prader-Willi Syndrome
13.5.5. Other Indications
13.6. Market Value Forecast, by Country/Sub-region, 2023-2031
13.6.1. Brazil
13.6.2. Mexico
13.6.3. Rest of Latin America
13.7. Market Attractiveness Analysis
13.7.1. By Route of Administration
13.7.2. By Distribution Channel
13.7.3. By Indication
13.7.4. By Country/Sub-region
14. Middle East & Africa Human Growth Hormone Market Analysis and Forecast
14.1. Introduction
14.2. Key Findings
14.3. Market Value Forecast, by Route of Administration, 2023-2031
14.3.1. Intravenous
14.3.2. Subcutaneous
14.3.3. Intramuscular
14.3.4. Oral
14.4. Market Value Forecast, by Distribution Channel, 2023-2031
14.4.1. Hospital Pharmacy
14.4.2. Online Pharmacy
14.4.3. Retail Pharmacy
14.4.4. Clinics
14.5. Market Value Forecast, by Indication, 2023-2031
14.5.1. Growth Hormone Deficiency
14.5.2. Turner Syndrome
14.5.3. Idiopathic Short Stature
14.5.4. Prader-Willi Syndrome
14.5.5. Other Indications
14.6. Market Value Forecast, by Country/Sub-region, 2023-2031
14.6.1. GCC Countries
14.6.2. South Africa
14.6.3. Rest of Middle East & Africa
14.7. Market Attractiveness Analysis
14.7.1. By Route of Administration
14.7.2. By Distribution Channel
14.7.3. By Indication
14.7.4. By Country/Sub-region
15. Competition Landscape
15.1. Market Player - Competitive Matrix (by Tier and Size of Companies)
15.2. Market Share Analysis, by Company (2022)
15.3. Company Profiles
15.3.1. Merck KGaA
15.3.1.1. Company Overview
15.3.1.2. Product Portfolio
15.3.1.3. SWOT Analysis
15.3.1.4. Financial Overview
15.3.1.5. Strategic Overview
15.3.2. Eli Lilly and Company
15.3.2.1. Company Overview
15.3.2.2. Product Portfolio
15.3.2.3. SWOT Analysis
15.3.2.4. Financial Overview
15.3.2.5. Strategic Overview
15.3.3. Pfizer Inc
15.3.3.1. Company Overview
15.3.3.2. Product Portfolio
15.3.3.3. SWOT Analysis
15.3.3.4. Financial Overview
15.3.3.5. Strategic Overview
15.3.4. Novo Nordisk A/S
15.3.4.1. Company Overview
15.3.4.2. Product Portfolio
15.3.4.3. SWOT Analysis
15.3.4.4. Financial Overview
15.3.4.5. Strategic Overview
15.3.5. Ipsen SA
15.3.5.1. Company Overview
15.3.5.2. Product Portfolio
15.3.5.3. SWOT Analysis
15.3.5.4. Financial Overview
15.3.5.5. Strategic Overview
15.3.6. Roche Holdings, Inc
15.3.6.1. Company Overview
15.3.6.2. Product Portfolio
15.3.6.3. SWOT Analysis
15.3.6.4. Financial Overview
15.3.6.5. Strategic Overview
15.3.7. Anhui Anke Biotechnology (Group) Co., Ltd.
